The Life Sciences Web Portal for German-speaking Europe
This is a free web portal for the life sciences in German-speaking Europe... » read more
- Arrowhead Acquires Novartis’ RNAi RnD Portfolio (2015-03-05)
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced the acquisition of Novartis' entire RNAi research and development portfolio and associated assets. The acquisition includes assignment ...
- Baxter BioScience Acquires SuppreMol GmbH for €200m (2015-03-04)
Acquisition Includes SuppreMol’s Early-Stage Pipeline of Protein Therapeutics for Autoimmune and Allergic Diseases Baxter International Inc. (NYSE:BAX) and SuppreMol GmbH today announced that Baxter has acquired SuppreMol for EUR 200 million (approximately $22...
- Funakoshi to Distribute Sygnis’ TruePrime Kits in Japan (2015-03-04)
> Distribution agreement for Japan, the second largest life science market in the world today > FUNAKOSHI is a leading Japanese life science distributor with focus on molecular biology, protein research, cell biology and diagnostics > TruePrime™ family for wh...
- Sciex, Labor Berlin Develop Forensic QTOF Reference Library (2015-03-02)
SCIEX announced today a research collaboration with Labor Berlin, the largest clinical laboratory in Germany, for the development of a hybrid Quadrupole Time-of-Flight (TOF) MS/MS reference library of relevant forensic chemical compounds. The library will cover tho...
- KfW Invests in Imevax in 2nd Closing of Series A Financing (2015-03-02)
ImevaX GmbH, a specialist in vaccines against pathogens of chronic infectious diseases, especially in H. pylori infections, announced today that KfW has joined the company's 2014 Series A investor syndicate through a second closing of the financing. The KfW inve...
- Zedira and Dr. Falk Pharma Enter Phase 1 Study with ZED1227 (2015-03-02)
Dr. Falk Pharma and Zedira announce the start of phase I clinical trials for the drug candidate ZED1227, a direct acting inhibitor of tissue transglutaminase. The small molecule targets the dysregulated transglutaminase within the small intestine in order to dampen...
- Roche and BioMed X to Develop Nanomaterial-based Biosensors (2015-02-24)
Roche and BioMed X announced today that they have entered into a collaboration agreement to establish a research group focusing on the development of a novel sensor technology platform based on new nanomaterials such as graphene. Outstanding early career scienti...
- Intrexon to Acquire ActoGenix for $60m in Cash and Shares (2015-02-13)
Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced it has entered into a definitive agreement to acquire ActoGeniX, a European clinical stage biopharmaceutical company forging a new frontier in cellular therapeutics. The proprietary T...
- Evotec Adopts ChemAxon’s ComplianceChecker (2015-02-12)
ChemAxon and Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced the licensing and deployment of ChemAxon’s Compliance Checker technology and content package to aid in correct handling and storage of chemical compounds used across ...
- XL-protein: MSD Animal Health Licenses PASylation Technology (2015-02-12)
XL-protein GmbH, Germany, a privately owned biopharmaceutical company, announced today that they have entered into a license agreement with MSD Animal Health (known as Merck Animal Health in the USA and Canada) to develop PASylated biopharmaceuticals for use in ani...
Life-Sciences-Germany.com is your doorway to the life sciences in German-speaking Europe!
[LSG] provides free, up-to-date and structured access to
in Germany, Austria and Switzerland.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSG] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to email@example.com and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)